155 related articles for article (PubMed ID: 37746942)
21. [Establishment and validation of a novel nomogram to predict overall survival after radical nephrectomy].
Xiong LB; Zou XP; Ning K; Luo X; Peng YL; Zhou ZH; Wang J; Li Z; Yu CP; Dong P; Guo SJ; Han H; Zhou FJ; Zhang ZL
Zhonghua Zhong Liu Za Zhi; 2023 Aug; 45(8):681-689. PubMed ID: 37580273
[No Abstract] [Full Text] [Related]
22. Establishment and validation of a nomogram to predict cancer-specific survival in pediatric neuroblastoma patients.
Chen W; Lin P; Bai J; Fang Y; Zhang B
Front Pediatr; 2023; 11():1105922. PubMed ID: 36937951
[TBL] [Abstract][Full Text] [Related]
23. Web-based nomogram and risk stratification system constructed for predicting the overall survival of older adults with primary kidney cancer after surgical resection.
Jiang L; Wang C; Tong Y; Jiang J; Zhao D
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11873-11889. PubMed ID: 37410141
[TBL] [Abstract][Full Text] [Related]
24. Construction of a novel clinical nomogram to predict cancer-specific survival in patients with primary malignant adrenal tumors: a large population-based retrospective study.
Li M; Duan X; You D; Liu L
Front Med (Lausanne); 2023; 10():1184607. PubMed ID: 37305122
[TBL] [Abstract][Full Text] [Related]
25. Score for the Risk and Overall Survival of Lung Metastasis in Patients First Diagnosed With Soft Tissue Sarcoma: A Novel Nomogram-Based Risk Assessment System.
Fan Z; Chi C; Tong Y; Huang Z; Song Y; You S
Technol Cancer Res Treat; 2022; 21():15330338211066240. PubMed ID: 35006028
[No Abstract] [Full Text] [Related]
26. Development and validation of a prognostic nomogram for predicting overall survival in patients with primary bladder sarcoma: a SEER-based retrospective study.
Li S; Liu X; Chen X
BMC Urol; 2021 Nov; 21(1):162. PubMed ID: 34823525
[TBL] [Abstract][Full Text] [Related]
27. A SEER-based nomogram accurately predicts prognosis in Ewing's sarcoma.
Zhan H; Mo F; Zhu M; Xu X; Zhang B; Liu H; Dai M
Sci Rep; 2021 Nov; 11(1):22723. PubMed ID: 34811459
[TBL] [Abstract][Full Text] [Related]
28. A nomogram of clinical and biologic factors to predict survival in children newly diagnosed with high-risk neuroblastoma: An International Neuroblastoma Risk Group project.
Moreno L; Guo D; Irwin MS; Berthold F; Hogarty M; Kamijo T; Morgenstern D; Pasqualini C; Ash S; Potschger U; Ladenstein R; Valteau-Couanet D; Cohn SL; Pearson ADJ; London WB
Pediatr Blood Cancer; 2021 Mar; 68(3):e28794. PubMed ID: 33205902
[TBL] [Abstract][Full Text] [Related]
29. Nomogram for predicting overall survival in children with neuroblastoma based on SEER database.
Liang SW; Chen G; Luo YG; Chen P; Gu JH; Xu QQ; Dang YW; Qin LT; Lu HP; Huang WT; Huang ZG; Gao L; Chen JB
Ann Surg Treat Res; 2020 Aug; 99(2):118-126. PubMed ID: 32802817
[TBL] [Abstract][Full Text] [Related]
30. Serum cholesterol level as a predictive biomarker for prognosis of Neuroblastoma.
Min J; Wu Y; Huang S; Li Y; Lv X; Tang R; Zhao H; Wang J
BMC Pediatr; 2024 Mar; 24(1):205. PubMed ID: 38519890
[TBL] [Abstract][Full Text] [Related]
31. Hyperdiploidy plus nonamplified MYCN confers a favorable prognosis in children 12 to 18 months old with disseminated neuroblastoma: a Pediatric Oncology Group study.
George RE; London WB; Cohn SL; Maris JM; Kretschmar C; Diller L; Brodeur GM; Castleberry RP; Look AT
J Clin Oncol; 2005 Sep; 23(27):6466-73. PubMed ID: 16116152
[TBL] [Abstract][Full Text] [Related]
32. An autophagy-related four-lncRNA signature helps to predict progression-free survival of neuroblastoma patients.
Wang J; Meng X; Chen K; Feng J
Front Oncol; 2022; 12():1014845. PubMed ID: 36530992
[TBL] [Abstract][Full Text] [Related]
33. Cross-cohort analysis identified an immune checkpoint-based signature to predict the clinical outcomes of neuroblastoma.
Zeng L; Xu H; Li SH; Xu SY; Chen K; Qin LJ; Miao L; Wang F; Deng L; Wang FH; Li L; Fu S; Liu N; Wang R; Li YQ; Wang HY
J Immunother Cancer; 2023 May; 11(5):. PubMed ID: 37130627
[TBL] [Abstract][Full Text] [Related]
34. Construction and Validation of Prognosis Nomogram for Metastatic Lung Squamous Cell Carcinoma: A Population-Based Study.
Liu Y; Sun M; Xiong Y; Gu X; Zhang K; Liu L
Technol Cancer Res Treat; 2022; 21():15330338221132035. PubMed ID: 36217877
[No Abstract] [Full Text] [Related]
35. [Clinical characteristics and prognostic analysis of 458 children with high-risk neuroblastoma in a single center].
Su Y; Ma XL; Wang HM; Qin H; Qin MQ; Zhang FQ; Jin M; Zhang DW; Chen CH; Zeng Q; He LJ; Ni X
Zhonghua Er Ke Za Zhi; 2020 Oct; 58(10):796-801. PubMed ID: 32987457
[No Abstract] [Full Text] [Related]
36. Bladder cancer survival nomogram: Development and validation of a prediction tool, using the SEER and TCGA databases.
Zhang Y; Hong YK; Zhuang DW; He XJ; Lin ME
Medicine (Baltimore); 2019 Nov; 98(44):e17725. PubMed ID: 31689813
[TBL] [Abstract][Full Text] [Related]
37. Prediction to the prognosis of children with neuroblastoma by nomogram based on the first-diagnosed inflammatory markers.
Zhang Y; Zhang C; Ma Y; Li C; Zhao Z; Peng L; Deng X; Zhou J; Wang S
Pediatr Surg Int; 2022 Nov; 39(1):17. PubMed ID: 36449181
[TBL] [Abstract][Full Text] [Related]
38. Development and validation of a nomogram model for cancer-specific survival of patients with poorly differentiated thyroid carcinoma: A SEER database analysis.
Jin S; Liu H; Yang J; Zhou J; Peng D; Liu X; Zhang H; Zeng Z; Ye YN
Front Endocrinol (Lausanne); 2022; 13():882279. PubMed ID: 36176465
[TBL] [Abstract][Full Text] [Related]
39. Development and validation of a prognostic nomogram for predicting cancer-specific survival in lymph node-negative elderly esophageal cancer patients: A SEER-based study.
Qin L; Chen L; Tie X; Guo X; Yang F; Liu Y
Medicine (Baltimore); 2023 Jul; 102(30):e34441. PubMed ID: 37505134
[TBL] [Abstract][Full Text] [Related]
40. Clinical significance of MYCN amplification and ploidy in favorable-stage neuroblastoma: a report from the Children's Oncology Group.
Schneiderman J; London WB; Brodeur GM; Castleberry RP; Look AT; Cohn SL
J Clin Oncol; 2008 Feb; 26(6):913-8. PubMed ID: 18281664
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
